A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

With immunotherapy increasingly making it out of the lab and into hospitals as a viable way to treat serious conditions like ...

Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the ...

Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and more.

A next-generation, anti-CD19 enhanced CAR T-cell therapy that secretes interleukin-18 achieved a response in 81% of lymphoma patients who failed previous CAR T-cell therapy. Duration of response ...

Patients with systemic lupus erythematosus who received autologous chimeric antigen receptor T-cell therapy enjoyed potent ...

Most people who have CAR T-cell therapy will get CRS. Another name for it is "cytokine storm." Usually, it isn't serious. CRS starts in the first 2 weeks after treatment.

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armore ...

I am grateful for everything I have, and so I feel like my job now is to show up, be present, accept and give love. To laugh as much as possible, and to take care of the gift that the stem cell ...

Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the therapy within the body could make the intervention cheaper and easier ...